NATUS MEDICAL INCORPORATED

(NTUS)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Natus Medical Incorporated Appoints Thomas J. Sullivan as President, Effective December 27, 2021

12/17/2021 | 04:01pm EDT

Natus Medical Incorporated announced the appointment of Thomas J. Sullivan as President effective December 27, 2021 and a focus on long-term growth. Earlier this year, the Board of Directors engaged a strategic consulting firm to assist it in developing a strategy to build upon Natus’ market leading positions. Following the review, the Board retained Egon Zehnder to conduct a succession planning process which reviewed a talented slate of internal and external candidates to lead Natus. In appointing Mr. Sullivan, the Board has selected a 20+ year medical device veteran with extensive global executive experience and diverse expertise in strategic planning, operational excellence, organizational development, business transformation, M&A, and public company leadership. Prior to joining Natus, Mr. Sullivan was the President & Chief Executive Officer of Spectrum Plastics Group, an industry leading medical device global contract manufacturer.


© S&P Capital IQ 2021
All news about NATUS MEDICAL INCORPORATED
05/17NATUS MEDICAL INVESTOR ALERT BY THE : Kahn Swick & Foti, LLC Investigates Adequacy of Pri..
BU
05/06NATUS MEDICAL INC Management's Discussion and Analysis of Financial Condition and Resu..
AQ
05/05NATUS MEDICAL INVESTOR ALERT BY THE : Kahn Swick & Foti, LLC Investigates Adequacy of Pri..
BU
05/05NATUS MEDICAL : Q1 Earnings Snapshot
AQ
05/05Earnings Flash (NTUS) NATUS MEDICAL INCORPORATED Reports Q1 EPS $0.22, vs. Street Est o..
MT
05/05Natus Medical Q1 Non-GAAP EPS, Revenue Rise
MT
05/05Natus Medical Incorporated Reports Earnings Results for the First Quarter Ended March 3..
CI
05/05Natus Medical Announces First Quarter 2022 Financial Results
AQ
04/19CORRECTION : Sector Update: Health Care Stocks Stumble Monday Afternoon
MT
04/18SHAREHOLDER ALERT : Weiss Law Investigates Natus Medical Incorporated
PR
More news
Financials (USD)
Sales 2022 495 M - -
Net income 2022 34,0 M - -
Net Debt 2022 - - -
P/E ratio 2022 33,1x
Yield 2022 -
Capitalization 1 121 M 1 121 M -
Capi. / Sales 2022 2,26x
Capi. / Sales 2023 2,17x
Nbr of Employees 1 400
Free-Float 98,1%
Chart NATUS MEDICAL INCORPORATED
Duration : Period :
Natus Medical Incorporated Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends NATUS MEDICAL INCORPORATED
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 1
Last Close Price 32,73
Average target price
Spread / Average Target -
EPS Revisions
Managers and Directors
Thomas J. Sullivan President, Chief Executive Officer & Director
Benjamin Drew Davies Chief Financial Officer & Executive Vice President
Joshua H. Levine Non-Executive Chairman
Ivan Pandiyan Senior Director-Research & Development
Seán Langan Vice President-Global Operations
Sector and Competitors
1st jan.Capi. (M$)
NATUS MEDICAL INCORPORATED37.93%1 121
THERMO FISHER SCIENTIFIC-17.75%209 146
DANAHER CORPORATION-23.92%179 203
INTUITIVE SURGICAL, INC.-38.05%79 897
SIEMENS HEALTHINEERS AG-18.32%64 383
EDWARDS LIFESCIENCES CORPORATION-25.24%60 217